Abstract
Brain 5-HT receptors have been classified in at least six subtypes (5-HT1A, 1B, 1C, 1D, 2 AND 3; Peroutka, 1988), among which the 5-HT1A subtype has been the focus of intense research during the last few years. This receptor type is located both presynaptically on the 5-HT cell bodies (somatodendritic receptors), predominantly in the dorsal and median raphe nuclei and postsynaptically, predominantly in the limbic system (Verge et al., 1985; Weissmann-Nanopoulos et al., 1985). Activation of presynaptic 5-HT1A receptors with 5-HT1A ligands inhibits serotonergic neurotransmission (Hamon et al., 1988; Hjorth and Magnusson, 1988; Sharp et al., 1989a, b) and the physiological role of these receptors is probably to provide the brain with an autoinhibitory feedback system controlling 5-HT neurotransmission. At the postsynaptic level, activation of 5-HT1A receptors results in neuronal inhibition, the consequences of which are not well understood (e.g. Sprouse and Aghajanian, 1988; Martin and Mason, 1987).
Preview
Unable to display preview. Download preview PDF.
References
Amsterdam, J. D., Berwish, N., Potter, L. and Rickeis, K. (1987). Open trial of gepirone in the treatment of depressive disorder. Curr. Ther. Res., 41, 185–93.
Aghajanian, G. K. and Wang, R. Y. (1978). In Lipton, M. A., Di Mascio, A. and Killam, K. F. (eds.), Psychopharmacology: A Generation of Progress, Raven, New York, 171–83.
Beer, M., Kennett, G. A. and Curzon, G. (1990). A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism. Eur. J. Pharmacol., 178, 179–87.
Benton, B. and Nastiti, K. (1988). The influence of psychotropic drugs on the ultrasonic calling of mouse pups. Psychopharmacology, 95, 99–102.
Bill, D. J., Fletcher, A. and Knight, M. (1989). Actions of 5-HT1A ligands and standard anxiolytics on mouse exploratory behaviour in a two-compartment light:dark arena. Br. J. Pharmacol., 98, 679P.
Blackburn, T. P., Kemp, J. D., Martin, D. A. and Cox, B. (1984). Evidence that 5-HT agonist-induced rotational behaviour in the rat is mediated via 5-HT1 receptors. Psychopharmacology, 83, 163–5.
Blier, P. and de Montigny, C. (1987). Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse, 1, 470–80.
Bockaert, J., Dumuis, A., Bouhelal, R., Sebben, M. and Cory, R. N. (1987). Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons. Arch. Pharmacol., 335, 588–92.
Carli, M. and Samanin, R. (1988). Potential anxiolytic properties of 8-hydroxy-2-(di-N-propylamino)tetralin, a selective serotonin1A receptor agonist. Psychopharmacology, 94, 84–91.
Carli, M., Prontera, C. and Samanin, R. (1989). Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone. Br. J. Pharmacol., 96, 829–36.
Cervo, L. and Samanin, R. (1987). Potential antidepressant properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist. Eur. J. Pharmacol., 144, 223–9.
Cervo, L., Grignaschi, G. and Samanin, R. (1988a). Different effects of intracerebral and systemic administration of buspirone in the forced swimming test: involvement of a metabolite. Life Sci., 43, 2095–102.
Cervo, L., Grignaschi, G. and Samanin, R. (1988b). 8-hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis. Eur. J. Pharmacol., 158, 53–9.
Chopin, P. and Briley, M. (1987). Animal models of anxiety: the effects of compounds that modify 5-HT neurotransmission. Trends Pharmacol. Sci., 8, 383–8.
Cooper, S. and Desa, A. (1987). Benzodiazepines and putative 5-HT1A agonists increase hypertonic saline consumption in rehydrating rats. Pharmacol. Biochem. Behav., 28, 187–91.
Critchley, M. A. E. and Handley, S. L. (1989). Dorsal raphe lesions abolish effects of 8-OH-DPAT and ipsapirone in the X-maze. Br. J. Pharmacol., 96, 309P.
Cutler, M. G. and Dixon, A. K. (1988). Effects of ipsapirone on the behaviour of mice during social encounters. Neuropharmacology, 27, 1039–44.
Csanalosi, I., Schweizer, E., Case, W. G. and Rickeis, K. (1987). Gepirone in anxiety: A pilot study. J. Clin. Psychopharm, 7, 31.
Davidson, T. L. (1990). The long-term effects of diazepam, lorazepam and buspirone on behavioural suppression by a shock signal. Prog. Neuropsychopharmacol. Biol. Psychiat., 14, 223–36.
Davis, M., Cassella, J. V. and Kehne, J. H. (1988). Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: Comparison with 8-OH-DPAT and ipsapirone. Psychopharmacology, 94, 14–20.
De Montigny, C., Blier, P. and Chaput, Y. (1990). Electrophysiological investigation of the effects of antidepressant treatments on serotonin receptors. In Paoletti, R., Vanhoutte, P. M., Brunello, N. and Maggi, F. M. (eds.), Serotonin: From Cell Biology to Pharmacology and Therapeutics, Kluwer, Dordrecht, 499–504.
De Vivo, M. and Maayani, S. (1986). Characterization of the 5-hydroxytryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J. Pharmacol. Exp., 238, 248–53.
De Vry, J. and Scheiber, R. (1990). Neuro-anatomical correlate of the discriminative stimulus effects of the 5-HT1A receptor ligands 8-OH-DPAT and ipsapirone in the rat. Psychopharmacology, 101, S67.
De Vry, J., Glaser, T. and Traber, J. (1990). 5HT1A/partial agonists as receptor anxiolytics. In Paoletti, R., Vanhoutte, P. M., Brunello, N. and Maggi, F. M. (eds.), Serotonin: From Cell Biology to Pharmacology and Therapeutics, Kluwer, Dordrecht, 517–22.
De Vry, J., Schreiber, R., Horvath, E. and Traber, J. (1989). Animal models of 5-HT1A receptor function. Pharmacopsychiat., 22, 194–5.
Dourish, C. T. (1987). Brain 5HT1A receptors and anxiety. In Dourish, C. T., Ahlenius, S. and Hutson, P. H. (eds.), Brain 5-HT1A Receptors, Ellis Horwood, Chichester, 261–77.
Dourish, C. T., Ahlenius, S. and Hutson, P. H. (1987). Brain 5-HT1A Receptors and Anxiety, Ellis Horwood, Chichester.
Dunn, R. W., Corbett, R. and Fielding, S. (1989). Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur. J. Pharmacol., 169, 1–10.
Eison, A. S., Eison, M. S., Stanley, M. and Riblet, L. A. (1986). Serotonergic mechanisms in the behavioural effects of buspirone and gepirone. Pharmacol. Biochem. Behav., 24, 701–7.
Engel, J., Hjorth, S., Svensson, K., Carlsson, A. and Liljequist, S. (1984). Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur. J. Pharmacol., 105, 365–8.
File, S. E. and Hyde, J. R. G. (1978). Can social interaction be used to measure anxiety? Br. J. Pharmacol., 62, 19–24.
Gardner, C. R. (1985). Pharmacological studies on the role of serotonin in animal models of anxiety. In Green, A. R. (ed.), Neuropharmacology of Serotonin, Oxford University Press, Oxford, 281–325.
Geller, I. and Seifter, J. (1960). The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally-induced conflict in the rat. Psychopharmacology, 1, 482–92.
Gilbert, F., Brazell, C., Tricklebank, M. D. and Stahl, S. M. (1988). Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration. Eur. J. Pharmacol., 147, 431–9.
Giral, P., Martin, P., Soubrié, P. and Simon, P. (1988). Reversal of helpless behaviour in rats by putative 5-HT1A agonists. Biol. Psychiatry, 23, 237–42.
Glaser, T., van Rooijen, L. A. A. and Traber, J. (1988). Functional interaction of novel anxiolytics with 5-HT1A-and adrenergic receptors. Psychopharmacology, 96, S351.
Gleeson, S. and Barrett, J. E. (1989). Discriminative stimulus effects of anxiolytics in the hippocampus. Soc. Neurosci. Abstr., 15, 633.
Gleeson, S., Ahlers, S. T., Mansbach, R. S., Foust, J. M. and Barrett, J. E. (1989). Behavioural studies with anxiolytic drugs. VI: Effects on punished responding of drugs interacting with serotonin receptor sybtypes. J. Pharmacol. Exp. Ther., 250, 809–17.
Glennon, R. A., Young, R. and Pierson, M. E. (1989). Stimulus properties of arylpiperazine second generation anxiolytics. In Bevan, P., Cools, A. R. and Archer, T. (eds.), Behavioural Pharmacology of 5-HT, Lawrence Erlbaum Associates, Hillsdale, New Jersey, 445–8.
Goa, K. L. and Ward, A. (1986). Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs, 32, 114–29.
Goodwin, G. M. (1989). The effects of antidepressant treatments and lithium upon 5-HT1A receptor function. Prog. Neuropsychopharmacol. Biol. Psychiat., 13, 445–51.
Goodwin, G. M., DeSouza, R. J., Green, A. R. and Heal, D. J. (1987). The pharmacology of the behavioural and hypothermic responses of the rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Psychopharmacology, 91, 506–11.
Goudie, A. J., Leathley, M., Deans, C. and Taylor, M. A. I. (1989). Tolerance to the behavioural effects of the selective 5-HT1A agent, ipsapirone. Behavioural Pharmacology, 1, 33–44.
Gower, A. J. and Tricklebank, M. D. (1988). Alpha2-adrenoceptor antagonist activity may account for the effects of buspirone in an anticonflict test in the rat. Eur. J. Pharmacol., 155, 129–37.
Graeff, E. O., Hunziker, M. H. L. and Graeff, F. G. (1989). Effects of ipsapirone and BAY R 1531 on learned helplessness. Brazilian J. Med. Biol. Res., 22, 1141–4.
Gray, J. A. (1982). The Neuropsychology of Anxiety: An Enquiry into the Function of the Septo-hippocampal System, Clarendon, Oxford.
Haleem, D. J., Kennett, G. A., Whitton, P. S. and Curzon, G. (1989). 8-OH-DPAT increases corticosterone but not other 5-HT1A receptor-dependent responses more in females. Eur. J. Pharmacol., 164, 435–43.
Hamon, M., Fattaccini, C.-M., Adrien, J., Gallissot, M.-C., Martin, P. and Gozlan, H. (1988). Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties. J. Pharmacol. Exp. Ther., 246, 745–52.
Hand, T. H., Marek, D. C., Seiden, J. and Seiden, L. S. (1989). Antidepressant-like effects of the 5-HT1A agonists buspirone, gepirone, 8-OH-DPAT and 5-MEODMT in rats on the DRL 72 sec schedule: differential blockade by methysergide and purported 5-HT1A antagonists. Soc. Neurosci. Abstr., 15, 1282.
Hard, E. and Engel, J. (1988). Effects of 8-OH-DPAT on ultrasonic vocalization and audiogenic immobility reaction in pre-weanling rats. Neuropharmacology, 27, 981–6.
Heller, A. H., Beneke, M., Kümmel, B., Spencer, D. and Kurtz, N. M. (1990). Ipsapirone: evidence for efficacy in depression. Psychopharmacol. Bull., in press.
Higgins, G. A., Bradbury, A. J., Jones, B. J. and Oakley, N. R. (1988). Behavioral and biochemical consequences following activation of 5-HT1-like and GABA receptors in the dorsal raphe nucleus of the rat. Neuropharmacology, 27, 993–1001.
Hirose, A., Tsuji, R., Shimizu, H., Tatsuno, T., Tanaka, H., Kumasaka, Y. and Nakamura, M. (1990). Inhibition of 8-hydroxy-2-(di-n-propylamino)tetralin and SM-3997, a novel anxiolytic drug, of the hippocampal rhythmical slow activity mediated by 5-hydroxytryptamine1A receptors. Naunyn-Schmiedeberg’s Arch. Pharmacol., 341, 8–13.
Hjorth, S. and Magnusson, T. (1988). The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in the rat brain in vivo. Arch. Pharmacol., 338, 463–71.
Howard, J. L. and Pollard, G. T. (1990). Effects of buspirone in the Geller—Seifter conflict test with incremental shock. Drug Dev. Res., 19, 37–49.
Hutson, P. H., Donohoe, T. P. and Curzon, G. (1987). Hypothermia induced by the putative 5-HT1A agonists LY165163 and 8-OH-DPAT is not prevented by 5-HT depletion. Eur. J. Pharmacol., 143, 221–8.
Johansson, C. E., Meyerson, B. J. and Höglund, A. U. (1990). The long-term effects of 8-hydroxy-2-(di-n-porpyl-amino)tetralin (8-OH-DPAT) on copulatory and exploratory behaviour in male rats. Eur. J. Pharmacol., 178, 1–9.
Kalkman, H. O. (1990). Discriminative stimulus properties of 8-OH-DPAT in rats are not altered by pretreatment with para-chlorophenylalanine. Psychopharmacology, 101, 39–42.
Kennett, G. A., Dourish, C. T. and Curzon, G. (1987a). Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. Eur. J. Pharmacol., 134, 265–74.
Kennett, G. A., Marcou, M., Dourish, C. T. and Curzon, G. (1987b). Single administration of 5-HT1A agonists decreases mediated responses: relationship to antidepressant-like action. Eur. J. Pharmacol., 138, 53–60.
Koenig, J. I., Meltzer, H. Y. and Gudelsky, G. A. (1988). 5-hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone. Pharmacol. Biochem. Behav., 29, 711–15.
Kostowski, W., Plaznik, A. and Stefanski, R. (1989). Intra-hippocampal buspirone in animal models of anxiety. Eur. J. Pharmacol., 168, 393–6.
Kümmel, B., Beneke, M., Krol, G., Schoellnhammer, G. and Spechtmeyer, H. (1988). Ipsapirone in the treatment of generalized anxiety disorders. Results of a phase II US-multicenter trial. Psychopharmacology, 96, S353.
Larsson, L.-G., Renyi, L., Ross, S. B., Svensson, B. and Ängeby-Möller, K. (1990). Different effects on the responses of functional pre-and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT. Neuropharmacology, 29, 85–91.
Luscombe, G. P., Martin, K. F., Hutchins, L. J., Gosden, J. and Buckett, W. R. (1988). Involvement of 5-HT1A receptors in the antidepressant-like effect of 8-OH-DPAT in a putative model of depression in mice. Br. J. Pharmacol., 95, 784P.
Luscombe, G. P., Martin, K. F., Hutchins, L. J. and Buckett, W. R. (1989). Attenuation of the hypothermia but not the antidepressant-like effect of 8-OH-DPAT following its repeated administration to mice. Br. J. Pharmacol., 96, 307P.
Maj, J., Deren, A., Golembiowska, K. and Moryl, E. (1989). Some central effects of ipsapirone, a new anxiolytic drug. Abstract book of the International Symposium on Serotonin: from Cell Biology to Pharmacology and Therapeutics, Florence, 183.
Marsden, C. A. (1989). In Tyrer, P. (ed.), Psychopharmacology of Anxiety, Oxford Medical Publications, Oxford, 3–27.
Martin, K. F. and Mason, R. (1987). Ipsapirone is a partial agonist at 5-hydroxytryptamine1A (5-HT1A) receptors in the rat hippocampus: Electrophysiological evidence. Eur. J. Pharmacol., 141, 479–83.
Martin, P., Beninger, R. J., Hamon, M. and Puech, A. J. (1990). Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist in the learned helplessness paradigm: evidence for a post-synaptic mechanism. Behav. Brain Res., 38, 135–44.
Meller, E., Goldstein, M. and Bohmaker, K. (1990). Receptor reserve for 5-HT1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-HT1A agonists. Mol. Pharmacol., 37, 231–7.
Naylor, R. and Costall, B. (1971). The relationship between the inhibition of dopamine uptake and the enhancement of amphetamine stereotypy. Life Sci., 10, 909–15.
O’Connor, J. J., Rowan, M. J. and Anwyl, R. (1989). Serotonergic involvement in the inhibitory effects of repeated buspirone treatment on synaptic transmission in the hippocampus. Eur. J. Pharmacol., 167, 21–9.
Peroutka, S. J. (1988). 5-hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization. Trends Neurosci., 11, 496–500.
Plaznik, A., Stefanski, R., Pucilowski, O. and Kostowski, W. (1990). Effects of intra-accumbens administration of dopamine agonists on stress-induced behavioral deficit. J. Pharm. Pharmacol., 42, 79–84.
Porsolt, R. D., Anton, G., Blavet, N. and Jalfre, M. (1978). Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol., 47, 379.
Press, D. Z., Wieland, S. and Lucki, I. (1989). Antidepressant-like effects of 5-HT1A agonists. Soci. Neurosci. Abstr., 15, 225.
Przegalinski, E., Tatarczynska, E. and Chojnacka-Wojcik, E. (1989). Anticonflict effect of ipsapirone, buspirone and gepirone is not mediated by their common metabolite 1–2-pyrimidinylpiperazine. J. Psychopharmacol., 3, 180–5.
Rodgers, R. J. and Shepherd, J. K. (1989). Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone. Psychopharmacology, 99, 374–80.
Rowan, M. J., Cullen, W. K. and Moulton, B. (1990). Buspirone impairment of performance of passive avoidance and spatial learning tasks in the rat. Psychopharmacology, 100, 393–8.
Schechter, L. E., Bolanos, F. J., Gozlan, H., Laporte, A.-M., Fattaccini, C.-M. and Hamon, M. (1991). Modulations of serotonergic neurotransmission by chronic ipsapirone in the rat. This volume.
Schefke, D. M., Fontana, D. J. and Commissaris, R. L. (1989). Anti-conflict efficacy of buspirone following acute versus chronic treatment. Psychopharmacology, 99, 427–9.
Schreiber, R. and De Vry, J. (1989). Involvement of the dorsal raphe nucleus in the discriminative stimulus properties of the 5-HT1A receptor agonist 8-OH-DPAT. Soc. Neurosci. Abstr., 15, 222.
Schreiber, R. and De Vry, J. (1990a). Neuro-anatomical correlate of the anxiolytic effects of the 5-HT1A receptor ligands 8-OH-DPAT, ipsapirone and buspirone in the rat. Psychopharmacology, 101, S52.
Schreiber, R. and De Vry, J. (1990b). Neuro-anatomical correlate of the antidepressant-like effects of ipsapirone and 8-OH-DPAT in the rat forced swimming test. Psychopharmacology, 101, S52.
Schweizer, E. E., Amsterdam, J. D. and Rickeis, K. (1986). Open trial of buspirone in the treatment of major depressive disorder. Psychopharmacol. Bull., 22, 183–6.
Schuurman, T., Benz, U., De Vry, J. and Traber, J. (1989). The effects of ipsapirone, buspirone, gepirone and diazepam in animal models of aggression, anxiety and depression. In Stefanis, C. N., Soldatos, C. R. and Rabavilas, A. D. (eds.), Psychiatry Today: Accomplishments and Promises, Excerpta Medica, International Congress Series, 899, 160.
Sharp, T., Bramwell, S. R. and Grahame-Smith, D. G. (1989a). 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br. J. Pharmacol., 96, 283–90.
Sharp, T., Bramwell, S. R., Clark, D. and Grahame-Smith, D. G. (1989b). In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity. J. Neurochem., 53, 234–40.
Sharp, T., Bramwell, S. R., Hjorth, S. and Grahame-Smith, D. G. (1989c). Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Br. J. Pharmacol., 98, 989–97.
Sleight, A. J., Smith, R. J., Marsden, C. A. and Palfreyman, M. G. (1988). Is the hyperphagic response to 8-OH-DPAT a model for 5-HT1A receptor responsiveness? Br. J. Pharmacol., 95, 875P.
Smith, L. M. and Peroutka, S. J. (1986). Differential effects of 5-hydroxytrypamine1A selective drugs on the 5-HT behavioral syndrome. Pharmacol. Biochem. Behav., 24, 1513–19.
Soubrié, P. (1986). Reconciling the role of central serotonin neurons in human and animal behavior. Behav. Brain Sci., 9, 319–64.
Soubrié, P. (1989). 5HT1A receptors: a bridge between anxiety and depression. In Bevan, P., Cools, A. R. and Archer, T. (eds.), Behavioural Pharmacology of 5-HT, Lawrence Erlbaum, Hillsdale, NJ, 337–52.
Söderpalm, B., Hjorth, S. and Engel, J. A. (1988). Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery’s conflict test. Pharmacol. Biochem. Behav., 32, 259–65.
Spencer, D. G., Glaser, T. and Traber, J. (1987). Serotonin receptor subtype mediation of the interoceptive discriminative stimuli induced by 5-methoxy-N,N-dimethyltryptamine. Psychopharmacology, 93, 158–66.
Sprouse, J. S. and Aghajanian, G. K. (1988). Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology, 7, 707–15.
Tatarczynska, E. and Chojnacka-Wojcik, E. (1989). Effects of 8-OH-DPAT and ipsapirone in the tests used for evaluation of the antidepressant action. Pol. J. Pharmacol. Pharm., 41, 321–30.
Tedeschi, R. E., Tedeschi, D. H., Mucha, A., Cook, L., Mattis, P. A. and Fellows, E. J. (1959). Effects of various centrally active drugs on fighting behavior in mice. J. Pharmacol. Exp. Ther., 129, 28–34.
Traber, J. and Glaser, T. (1987). 5-HT1A receptor-related anxiolytics. Trends Pharmacol. Sci., 8, 432–7.
Traber, J., Davies, M. A., Dompert, W. U., Glaser, T., Schuurman, T. and Seidel, P.-R. (1984). Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. Brain Res. Bull., 12, 741–4.
Tricklebank, M. D., Forler, C. and Fozard, J. R. (1985). The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioral response of 8-hydroxy-2-(di-n-propylamino) tetralin in the rat. Eur. J. Pharmacol., 106, 271–82.
Verge, D., Daval, G., Patey, A., Gozlan, H., El Mestikawy, S. and Hamon, M. (1985). Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. Eur. J. Pharmacol., 113, 463–4.
Vogel, J. R., Beer, B. and Clody, D. E. (1971). A single reliable conflict procedure for testing anti-anxiety agents. Psychopharmacology, 21, 1–7.
Weissmann-Nanopoulos, D., Mach, E., Magre, J., Demassey, Y. and Pujol, J.-F. (1985). Evidence for the localization of 5-HT1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem. Int., 7, 1061–72.
Wettstein, J. G. (1988). Behavioural effects of acute and chronic buspirone. Eur. J. Pharmacol., 151, 341–4.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1991 Macmillan Publishers Limited
About this chapter
Cite this chapter
De Vry, J., Glaser, T., Schuurman, T., Schreiber, R., Traber, J. (1991). 5-HT1A Receptors in Anxiety. In: Briley, M., File, S.E. (eds) New Concepts in Anxiety. Palgrave, London. https://doi.org/10.1007/978-1-349-11847-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-349-11847-2_7
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-11849-6
Online ISBN: 978-1-349-11847-2
eBook Packages: EngineeringEngineering (R0)